WaveMan
WaveMan · Company
NP · Neptune Insurance Holdings Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

NP Neptune Insurance (NP) Insider Trading, Ownership & Congress Trades

Insurance · Insurance agents, brokers & service · CIK 0002067129
Quote by TradingView
Form 144 · 5
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

What the filings say about NP

Insiders, 180 days
-$424.4M net sold
7 sellers · 36% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$125.5M
5 notices

Neptune Insurance insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Neptune Insurance Holdings Inc. insiders sold a net $424.4M of stock across 26 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Duffy Matthew Paul
President & Chief Risk Officer
SELL
2026-10-09 SECtraded 2026-10-08
53,639
$1.5M
-1.9%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Oct 6, 2026.
  • The trade is 2.8% of the 1,910,600 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: President & Chief Risk Officer Duffy Matthew Paul sold about $1.5M of NP under a 10b5-1 plan on Oct 8, 2026; 1 other insider sold within 30 days.
Duffy Matthew Paul
President & Chief Risk Officer
SELL
2026-10-09 SECtraded 2026-10-08
30,802
$876.8K
-1.9%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Oct 6, 2026.
  • The trade is 1.6% of the 1,879,798 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: President & Chief Risk Officer Duffy Matthew Paul sold about $876.8K of NP under a 10b5-1 plan on Oct 8, 2026; 1 other insider sold within 30 days.
Duffy Matthew Paul
President & Chief Risk Officer
SELL
2026-10-07 SECtraded 2026-10-06
41,392
$1.1M
+0.0%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Oct 2, 2026.
  • The trade is 2.1% of the 1,964,239 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: President & Chief Risk Officer Duffy Matthew Paul sold about $1.1M of NP under a 10b5-1 plan on Oct 6, 2026; 1 other insider sold within 30 days.
Duffy Matthew Paul
President & Chief Risk Officer
SELL
2026-10-05 SECtraded 2026-10-02
38,537
$1.1M
+4.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 1.9% of the 2,006,831 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: President & Chief Risk Officer Duffy Matthew Paul sold about $1.1M of NP under a 10b5-1 plan on Oct 2, 2026; 1 other insider sold within 30 days.
Duffy Matthew Paul
President & Chief Risk Officer
SELL
2026-10-05 SECtraded 2026-10-02
1,200
$34.2K
+4.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 0.1% of the 2,005,631 shares held after it.
  • 1 other insider sold within 30 days.
Insider activity: President & Chief Risk Officer Duffy Matthew Paul sold about $34.2K of NP under a 10b5-1 plan on Oct 2, 2026; 1 other insider sold within 30 days.
26 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 21 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$424.4M over 180 days
-$125.6M over 90 days · -$415.1M of it by a 10%+ holder
the lowest in Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+33.7% year over year
more than 83% of Insurance
Margin
23.4% net margin
more than 79% of Insurance
Buybacks
$31.9M repurchased, FY to 2026-09-30
below 79% of Insurance
Short interest
6.0% of the float short (float per yahoo 2026-10-26) · 3.8 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 9President & Chief Risk Officer Duffy Matthew Paul sold $4.6M under a 10b5-1 plan (5 trades, Oct 2 to Oct 8)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 2Officer MATTHEW DUFFY filed to sell $4.5M by Oct 2 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch NP

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+14.7%12M
-31%-7%+17%+42%2025-102025-122026-022026-042026-062026-082026-10 2026-05-15 · FTV NE-Aggregator, LLC sold $138.7M2026-05-15 · Bregal Sagemount Management LP sold $121.2M2026-07-29 · FTV VII, L.P. sold $62.0M2026-07-29 · BSIV Hold 101, LP sold $54.2M2026-05-19 · FTV NE-Aggregator, LLC sold $20.8M2026-05-19 · Bregal Sagemount Management LP sold $18.2M2026-08-13 · Steiner James sold $1.8M2026-09-14 · Carlon Jonathan Winant sold $1.6M2026-10-08 · Duffy Matthew Paul sold $1.5M2026-08-12 · Steiner James sold $1.3M2026-10-06 · Duffy Matthew Paul sold $1.1M2026-10-02 · Duffy Matthew Paul sold $1.1M2026-03-13 · Burgess Trevor R bought $935.5K2026-10-08 · Duffy Matthew Paul sold $876.8K2026-02-20 · Vostrizansky Michael Warren bought $494.5K2026-10-02 · Duffy Matthew Paul sold $34.2K2026-10-02 · MATTHEW DUFFY filed to sell $4.5M2026-09-14 · Jonathan Winant Carlon filed to sell $1.6M2026-08-12 · James Steiner filed to sell $3.2M2026-07-29 · BSIV HOLD 101, LP filed to sell $54.2M2026-07-29 · FTV VII, L.P. filed to sell $62.0M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns NP: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in NP

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

NP planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
MATTHEW DUFFY
Filed 2026-10-02
$4.5M
Jonathan Winant Carlon
Filed 2026-09-14
$1.6M
James Steiner
Filed 2026-08-12
$3.2M
BSIV HOLD 101, LP
Filed 2026-07-29
$54.2M
FTV VII, L.P.
Filed 2026-07-29
$62.0M
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $424.4M sold by insiders over 180 days, $125.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLTRVMKLOSCRGL

NP financials

Revenue growth
+33.7%
XBRL, annual
Net margin
23.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$197.0M
four quarters, 2025-10-01 to 2026-09-30
Net margin, TTM
+22.7%
net income over revenue, 2025-10-01 to 2026-09-30
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Cash flow to debt
n/a
no debt to cover
Return on equity
n/a
average equity is zero or negative
Return on assets
+46.2%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on invested capital
n/a
invested capital is zero or negative
Return on capital employed
+2,059%
operating income (EBIT proxy) over average of 2025-09-30 and 2026-09-30 minus current liabilities
P/E, trailing
79.00x
close 2026-10-23 over four quarters of diluted EPS, 2025-10-01 to 2026-09-30
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-12
Revenue$159.6M$119.3M$84.9M
Operating income$71.0M$68.4M$45.4M
Net income$37.4M$34.6M$17.9M
EPS (diluted)-0.260.160.10
Operating cash flow$51.7M$49.9M$18.6M
Cash$8.0M$7.1Mn/a
Long-term debt$0$125.1Mn/a
SEC XBRL, fiscal years, as known on 2026-10-27

NP Stock Sonar score 4/7 axes

Find similar shapesCompare

NP ranks highest on profitability (99th percentile) and growth (83rd), and lowest on insider conviction (1st), among Insurance peers.

Profitability
100
Inputs
  • Return on equityaverage equity is zero or negative
  • Return on assets+46.2% · 100 pct, sector of 122
  • Return on invested capitalinvested capital is zero or negative
  • Return on capital employed+2059% · 100 pct, universe of 3,236
Growth
83
Inputs
  • Revenue growth, YoY+33.7% · 83 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
1
Inputs
  • Net Form 4 buying (codes P and S), 180d-$419.8M · 1 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Risk and compliance
23
Inputs
  • Short interest, % of float+6.0% · 23 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Institutional and government, US patents
  • Financial health needs 1 of 2 inputs, 0 present: equity is zero or negative, the ratio has no meaning; no debt to cover
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

NP filings, in plain words

Are Neptune Insurance insiders buying or selling NP?

In the 180 days to 2026-10-27, Neptune Insurance insiders were net sellers, a net $424.4M across purchases and sales reported on Form 4, by 7 sellers.

Are there planned insider sales of NP?

Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $125.5M of stock; the latest, by MATTHEW DUFFY, was filed 2026-10-02.

Read the full summary

In the 180 days to 2026-10-27, Neptune Insurance insiders were net sellers of NP, a net $424.4M across purchases and sales reported on Form 4 by 7 sellers. Most of that figure, $415.1M, came from a holder of 10% or more rather than an officer or director. 36% of the 14 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $125.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies